2-(3,5-Difluorophenyl)-5,5-dimethyl-1,3,2-dioxaborinane, 95.0%, 250mg

(4s)-4-Isopropyl-5,5-diphenyl-3-[(2r,3s)-4,4,4-trifluoro-3-hydroxy-2,3-dimethyl-butanoyl]oxazolidin-2-one, 98%, 5g

Cafeína anhidra, mínimo 98,5 %, para bioquímica, 500 g, envase de plástico.

4-Methylphenylurea, 95.0%, 10g

[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid, 95.0%, 10g

3-ethyl-1,2,4-oxadiazol-5-ol, 95.0%, 5g

2-BROMO-4-CHLORONICOTINIC ACID, 95.0%, 25g

fmoc-thr(tbu)-opfp, 5g

Methyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 97.0%, 5g

(S)-2-Phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 95.0%, 250mg

Formic Acid, 99.0%, 25g

5-Cyclopropaneamido-3-methylthiophene-2-carboxylic acid, 97%, 100mg

2-METHYL-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDIN-4(3H)-ONE, 95.0%, 250mg